Molecular Immunology Unit, Research Centre for Infection and Immunity, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK,
Transgenic Res. 2013 Dec;22(6):1225-9. doi: 10.1007/s11248-013-9730-7. Epub 2013 Jul 13.
The marshmallow plant (Althaea officinalis L.) has been used for centuries in medicine and other applications. Valuable secondary metabolites have previously been identified in Agrobacterium rhizogenes-generated transgenic 'hairy' roots in this species. In the present study, transgenic roots were produced in A. officinalis using A. rhizogenes. In addition to wild-type lines, roots expressing the anti-human immunodeficiency virus microbicide candidate, cyanovirin-N (CV-N), were generated. Wild-type and CV-N root lines were transferred to liquid culture and increased in mass by 49 and 19 % respectively over a 7 day culture period. In the latter, the concentration of CV-N present in the root tissue was 2.4 μg/g fresh weight, with an average secretion rate into the growth medium of 0.02 μg/ml/24 h. A. officinalis transgenic roots may therefore in the future be used not only as a source of therapeutic secondary metabolites, but also as an expression system for the production of recombinant pharmaceuticals.
药蜀葵(Althaea officinalis L.)在医学和其他领域已有数百年的应用历史。先前已在该物种的发根农杆菌(Agrobacterium rhizogenes)生成的转基因“毛状”根中鉴定出有价值的次生代谢产物。本研究中,利用发根农杆菌在药蜀葵中生成了转基因根。除了野生型品系,还生成了表达抗人类免疫缺陷病毒候选杀微生物剂氰基病毒素-N(CV-N)的根系。在 7 天的培养期内,野生型和 CV-N 根系分别增加了 49%和 19%的质量。在后一种情况下,根组织中存在的 CV-N 浓度为 2.4μg/g 鲜重,平均分泌到生长培养基中的速率为 0.02μg/ml/24h。因此,未来药蜀葵转基因根不仅可以用作治疗性次生代谢产物的来源,还可以用作生产重组药物的表达系统。